:: Library Catalog

Bibliographische Detailangaben
1. Verfasser:	Hanamura, Satoshi
Format:	Recurso digital
Sprache:	Englisch
Veröffentlicht:	Zenodo 2019
Schlagworte:	0-Sphere model
Online-Zugang:	https://doi.org/10.5281/zenodo.17759726
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beyond the Standard Model: Neutrino Oscillations and the Search for New Physics
von: Hanamura, Satoshi
Veröffentlicht: (2023)

Liver iron concentration thresholds: Where do they really come from?
von: Lukas Müller, et al.
Veröffentlicht: (2025)

Exciting science from the 16th International Conference on Thalassemia and Hemoglobinopathies
von: Dimitrios Farmakis, et al.
Veröffentlicht: (2024)

Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium
von: Cristina A. Tentori, et al.
Veröffentlicht: (2024)

Lower efficacy of transfusion of red blood cells from donors with sickle cell trait
von: Monika Dzieciatkowska, et al.
Veröffentlicht: (2026)

Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP Registry
von: Inés Gómez‐Seguí, et al.
Veröffentlicht: (2025)

Testicular large B‐cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL
von: Alfredo Rivas‐Delgado, et al.
Veröffentlicht: (2024)

Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab era
von: Abdul‐Hamid Bazarbachi, et al.
Veröffentlicht: (2025)

Hematology in times of crisis: Lessons learned and strategic priorities from the EHA–ASH Joint Workshop on Ukraine
von: Oleksandr Istomin, et al.
Veröffentlicht: (2026)

Pharmacological inhibition of sclerostin protects bone from B‐cell acute lymphoblastic leukemia‐mediated destruction
von: Vincent Kuek, et al.
Veröffentlicht: (2026)

Who owns that blood? Recontacting donors with results from genetic testing after allogeneic hematopoietic cell transplantation
von: Mirjam E. Belderbos, et al.
Veröffentlicht: (2025)

Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia
von: Bela Patel, et al.
Veröffentlicht: (2024)

Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter Registry
von: David F. Moreno, et al.
Veröffentlicht: (2024)

Clonal hematopoiesis dynamics influences long‐term outcomes of follicular lymphoma: Results from FIL FOLL12 trial
von: Nawar Maher, et al.
Veröffentlicht: (2026)

Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study
von: Sonia Morè, et al.
Veröffentlicht: (2025)

Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA
von: Amira Marouf, et al.
Veröffentlicht: (2025)

Elevated serum heme oxygenase‐1 in pediatric sickle cell disease: Insights from the SickleGenAfrica Network
von: Anna M. Sowa, et al.
Veröffentlicht: (2025)

Sequencing BCMA‐ and GPRC5D‐targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network
von: Niels W. C. J. van de Donk, et al.
Veröffentlicht: (2025)

Daratumumab‐based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study
von: Meral Beksac, et al.
Veröffentlicht: (2026)

Cumulative review of cardiac failure with acalabrutinib in the treatment of chronic lymphocytic leukemia using data from clinical trials and postmarketing experience
von: Paolo Ghia, et al.
Veröffentlicht: (2025)

Early progression beyond first‐line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study
von: Alberto Bavieri, et al.
Veröffentlicht: (2024)

Long‐term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM‐3 study
von: Michael H. Tomasson, et al.
Veröffentlicht: (2024)

Mitochondrial retention in mature red blood cells from patients with sickle cell disease is associated with stress erythropoiesis but not with proinflammatory state
von: Marc Romana, et al.
Veröffentlicht: (2024)

Mitigation of atrial fibrillation‐related complications with antithrombotic and cytoreductive therapy in patients with Myeloproliferative Neoplasms: Implications from the GSG‐MPN bioregistry
von: Hyunyee Rosa Cho, et al.
Veröffentlicht: (2025)

Correction to Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study
Veröffentlicht: (2025)

How to diagnose acid sphingomyelinase deficiency (ASMD) and Niemann–Pick disease type C from bone marrow and peripheral blood smears
von: Sandrine Girard, et al.
Veröffentlicht: (2024)

The role of time to first progression and fitness status in elderly patients with mantle cell lymphoma: Results from the ELDERLY MANTLE‐FIRST study
von: Francesca Maria Quaglia, et al.
Veröffentlicht: (2025)

Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health survey
von: Claire N. Harrison, et al.
Veröffentlicht: (2025)

The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study
von: Andrew D. Zelenetz, et al.
Veröffentlicht: (2024)

Serum TARC dynamics during anti‐PD1‐based first‐line Hodgkin lymphoma treatment: An analysis from the GHSG NIVAHL trial
von: Wouter J. Plattel, et al.
Veröffentlicht: (2025)

The role of trephine bone marrow biopsies in the era of measurable residual disease — Results from the CLL10 trial of the German CLL Study Group (GCLLSG)
von: Nadine Kutsch, et al.
Veröffentlicht: (2024)

Operational burden and fragmented implementation in CAR T‐cell therapy: Insights from a multinational survey by the GoCART Coalition and the JACIE Quality Managers Committee
von: Nick van Sinderen, et al.
Veröffentlicht: (2025)

Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group
von: Pierre Sesques, et al.
Veröffentlicht: (2026)

Extracellular vesicles from chronic lymphocytic leukemia cells promote leukemia aggressiveness by inducing the differentiation of monocytes into nurse‐like cells via an RNA‐dependent mechanism
von: Nathan Dubois, et al.
Veröffentlicht: (2025)

Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)‐MCL0208 clinical trial
von: Francesca Cordero, et al.
Veröffentlicht: (2026)

Clinical impact of immunoglobulin heavy chain repertoire in mantle cell lymphoma: A study from the Fondazione Italiana Linfomi (FIL) Phase III MCL0208 trial
von: Simone Ragaini, et al.
Veröffentlicht: (2026)

Improved post‐transplant outcomes since 2000 for Ph‐positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working Party
von: Ali Bazarbachi, et al.
Veröffentlicht: (2025)

CHIC: A machine learning framework for inferring the presence of high‐risk clonal hematopoiesis using complete blood count data from 431,531 UK Biobank participants
von: William G. Dunn, et al.
Veröffentlicht: (2025)

Outcomes of patients with relapsed or refractory primary mediastinal B‐cell lymphoma treated with anti‐CD19 CAR‐T cells: CARTHYM, a study from the French national DESCAR‐T registry
von: Jean Galtier, et al.
Veröffentlicht: (2025)

Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)
von: Fabio Efficace, et al.
Veröffentlicht: (2024)

Ähnliche Einträge

Ähnliche Einträge